JAZZ Jazz Pharmaceuticals Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
23:48
Oct 09
Oct 09
CNBC
Jazz Pharmaceuticals yes into JPM conference.
Cramer says yes to Jazz Pharmaceuticals, a profitable biotech, and expects biotech to do well into the JPMorgan healthcare conference.
JAZZ
Jazz Pharmaceuticals
Long
1ST
—
—
09:20
Jan 24
Jan 24
r/biotech_stocks
Long JAZZ ahead of PDUFA with 92% ML score.
The author's ML model holds JAZZ long ahead of a PDUFA catalyst in 19 days, assigning a 92% confidence score for a positive outcome. A favorable FDA decision could move the stock toward the $197.24 target; the trade is invalidated below the $157.79 stop loss.
JAZZ
Jazz Pharmaceuticals
Long
1ST
—
—
About JAZZ Investor Commentary
Across the available history and selected sources, Buzzberg tracks JAZZ (Jazz Pharmaceuticals) across 5 sources: 2 bullish vs 0 bearish calls from 5 authors. Historical directional balance: 22% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 9 total trade ideas tracked. Latest voices: Jim Cramer, u/DrinkConscious9173.